Metraipolis › archive › dc_4e8d322d8d8e
Neoadjuvant chemotherapy-induced immune remodeling in ovarian cancer: implications for TIL dynamics and combination immunotherapy — Europe PMC PMID:41798957
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41798957
- DOI
- 10.3389/fimmu.2026.1757366
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T15:07:55.825Z
- SHA-256 of the archived text
654be182cf8f80e8c8bb8a0905dd271241e56550efdc24f2d106da02b4fdb27a- Stable URL of this page
https://metraipolis.com/documento/dc_4e8d322d8d8e
How to cite
Neoadjuvant chemotherapy-induced immune remodeling in ovarian cancer: implications for TIL dynamics and combination immunotherapy — Europe PMC PMID:41798957 — Europe PMC (en), https://europepmc.org/article/MED/41798957 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e8d322d8d8e (Metraipolis archive dc_4e8d322d8d8e, sha256 654be182cf8f80e8c8bb8a0905dd271241e56550efdc24f2d106da02b4fdb27a)
BibTeX
@misc{dc4e8d322d8d8e,
title = {Neoadjuvant chemotherapy-induced immune remodeling in ovarian cancer: implications for TIL dynamics and combination immunotherapy — Europe PMC PMID:41798957},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41798957},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e8d322d8d8e; sha256 654be182cf8f80e8c8bb8a0905dd271241e56550efdc24f2d106da02b4fdb27a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41798957. Agents can read the archived copy with the MCP tool read_document.